Free Trial
OTCMKTS:OASMY

Vivesto (OASMY) Stock Price, News & Analysis

Vivesto logo
$0.05 0.00 (0.00%)
(As of 11/21/2024 ET)

About Vivesto Stock (OTCMKTS:OASMY)

Key Stats

Today's Range
$0.05
$0.05
50-Day Range
$0.05
$0.05
52-Week Range
$0.05
$0.05
Volume
N/A
Average Volume
104 shs
Market Capitalization
$8.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Receive OASMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivesto and its competitors with MarketBeat's FREE daily newsletter.

OASMY Stock News Headlines

Vivesto AB DRC (OASMY)
Vivesto AB ADR OASMY
Trump’s Victory Just Kicked the Door Open to a…
This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…
OMX Stockholm Health Care GI (SX20GI)
Oasmia Pharmaceutical AB ADR (OASMY)
See More Headlines

OASMY Stock Analysis - Frequently Asked Questions

Vivesto's stock was trading at $0.02 at the beginning of 2024. Since then, OASMY stock has increased by 150.0% and is now trading at $0.05.
View the best growth stocks for 2024 here
.

Shares of OASMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OASMY
Employees
20
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100,000.00
Book Value
$0.18 per share

Miscellaneous

Free Float
N/A
Market Cap
$8.97 million
Optionable
Not Optionable
Beta
21.84
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (OTCMKTS:OASMY) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners